Company Profiles

driven by the PitchBook Platform

AIKO Biotechnology

Description

Developer of drugs for pain management and opioid addiction. The company focuses on the discovery and validation of therapeutic compounds for the treatment of pain and the side effects associated with prescription opioid pain reliever use, such as opioid-induced bowel dysfunction, addiction and abuse.

2007

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$1.2M

Latest Deal Amount

$2.2M

Total Amount Raised

Description

Developer of drugs for pain management and opioid addiction. The company focuses on the discovery and validation of therapeutic compounds for the treatment of pain and the side effects associated with prescription opioid pain reliever use, such as opioid-induced bowel dysfunction, addiction and abuse.

Website:

www.aikobiotech.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Other Pharmaceuticals and Biotechnology

Primary Office

2 Union Street Suite 501 Portland, ME 04101United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AIKO Biotechnology's full profile, request a free trial.

AIKO Biotechnology Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AIKO Biotechnology Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Action EquityVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Maine Technology InstituteNot-For-Profit Venture Capital000 0000000 0000
Maine Venture FundVenture CapitalMinority000 0000000 0000
National Institute on Drug Abuse (NIDA)Other000 0000000 0000
Action Equity Venture Capital
Individual Investor Angel (individual)
Maine Technology Institute Not-For-Profit Venture Capital
Maine Venture Fund Venture Capital
National Institute on Drug Abuse (NIDA) Other

AIKO Biotechnology Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Wolfgang SadeeCo-Founder, Chief Scientific Officer & Board Member
Brian DallaireClinical Director
Wolfgang Sadee Co-Founder, Chief Scientific Officer & Board Member
Brian Dallaire Clinical Director

AIKO Biotechnology Board Members (3)

NameRepresentingRoleSinceContact
Info
David Anderson Ph.DSupply Chain VenturesManaging Director000 0000
Paul Goldenheim MDSelfBoard Member000 0000
Wolfgang SadeeAIKO BiotechnologyCo-Founder, Chief Scientific Officer & Board Member000 0000
David Anderson Ph.D Managing Director Supply Chain Ventures
Paul Goldenheim MD Board Member Self
Wolfgang Sadee Co-Founder, Chief Scientific Officer & Board Member AIKO Biotechnology
Request full access to PitchBook